Gil Van Bokkelen, Ph.D.

Dr. Van Bokkelen is chairman and chief executive officer of Athersys, Inc., a biopharmaceutical company that is focused on developing regenerative medicine therapies to treat significant unmet medical needs. Dr. Van Bokkelen received his Ph.D. degree in genetics from the Stanford University School of Medicine and earned degrees in both economics and molecular biology at the University of California, Berkeley. In addition to his duties at Athersys, Dr. Van Bokkelen serves as chairman of the board of governors for the National Center for Regenerative Medicine. From 2010 through 2012, he also served as chairman of the Alliance for Regenerative Medicine, a Washington D.C.-based non-profit organization whose mission is to educate key policy makers and others about the potential of regenerative medicine and the impact it can have on our healthcare system. He also serves on various boards, including the Biotechnology Industry Organization, as well as on the advisory boards of the McGowan Institute for Regenerative Medicine, and the Regenerative Medicine Foundation. He is an accomplished speaker, having given keynote addresses at leading scientific conferences and events, as well as numerous presentations at healthcare and regenerative medicine forums. He has also received a range of awards, including the Ernst & Young Entrepreneur Of The Year Award and the Anthem – Blue Cross and Blue Shield Visionary in Business Award.

Comments are closed.